Monday, March 25, 2019 1:04:14 PM
One case frequently referenced is the FDAs legal action against Regenerative Sciences, LLC. Information can be found here: D.C. Circuit Rules That FDA Can Regulate Autologous Stem Cells
IMPORTANT FACTUAL DIFERENCES BETWEEN USRM and REGENERATIVE:
1. Regenerative used a mixture of three types of human tissues and antibiotics, USRM uses only stem cells, no mixture
2. Regenerative cultured the stem cells. USRM only puts back the stem cells that they removed.
3. Regenerative didn't complete the procedure in a same-day visit like does USRM
4. Regenerative lost their case but are still actively in business
Note: Regenerative mixed bone marrow, blood, cultured stem cells and doxycycline (antibiotic). This product mixture is materially different than USRM’s adipose stem cell, which isn't a mixture, as a patient's own stem cells are exclusively what's injected into their body.
So, will the Federal Court see the difference between Regenerative's mixture and USRM's sole tissue? Will the Court see that USRM is a same-day procedure? And that these facts should deem the procedures taught nad performed are under a physicians right to practice medicine. I hope so.
Interesting to note that Regenerative, having lost the case, is still actively in business. Here is a note appearing on their website to explain their business
In conclusion, if USRM loses to the FDA, there is a strong precedent that USRM could remain actively engaged in Stem Cell research development and treatment.
My post are for entertainment purpose only
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM